The targets listed are TP53, EGFR, AKT1, IL6, TNF, STAT3, IL1B, CTNNB1, SRC, MYC, JUN, and INS, which are likely to be the primary focus of DSD in the treatment of MI. The gene discussed is CTNNB1; the disease is disorder of sexual differentiation.